How much 10 drugs will cost under Medicare price negotiation

On Aug. 15, the U.S. Centers for Medicare & Medicaid Services (CMS) announced the prices for the first 10 drugs selected for negotiations with pharmaceutical makers who supply drugs for the Medicare Part D program.

The new prices will go into effect in 2026 with estimated savings of $6 billion for taxpayers, and another $1.5 billion in savings for out-of-pocket costs for beneficiaries.

So what are the drugs?

This slideshow includes the drug name, commonly treated conditions, prices and savings. The data come from the White House and CMS.